HDAC9 and lung carcinoma: To further advance the knowledge related to PD-L1-mediated immune escape, the impact of the HDAC inhibitors on the expression levels of PD-L1 was systematically analyzed in his study using the H460 and HCC827 lung cancer cells (Figure 11).